Goodwill and Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Finite-Lived Intangible Assets

The Company’s amortizable and unamortizable intangible assets at March 31, 2018 and December 31, 2017 are as follows:



	March 31, 2018							December 31, 2017
Goodwill and Intangible Assets:	Gross Value		Accumulated Amortization			Net Carrying Amount		Gross Value		Accumulated Amortization			Net Carrying Amount

Amortizable intangible assets:
Acquired developed technology - Noctiva	$	73,111	$	(2,781	)	$	70,330	$	73,111	$	(1,401	)	$	71,710
Acquired developed technology - Vazculep	12,061		(9,820		)	2,241		12,061		(9,616		)	2,445
Acquired product marketing rights ⁽¹⁾	—		—			—		16,600		(2,132		)	14,468
Acquired developed technology ⁽¹⁾	—		—			—		4,300		(634		)	3,666
Total amortizable intangible assets	$	85,172	$	(12,601	)	$	72,571	$	106,072	$	(13,783	)	$	92,289

Unamortizable intangible assets:
Goodwill	$	18,491	$	—		$	18,491	$	18,491	$	—		$	18,491
Total unamortizable intangible assets	$	18,491	$	—		$	18,491	$	18,491	$	—		$	18,491

⁽¹⁾ These intangible assets were assumed by the buyer as part of the disposition of the pediatrics products on February 16, 2018. See Note 12 : Divestiture of the Pediatric Assets.

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense

Estimated amortization of intangible assets for the next five years is as follows:



Estimated Amortization Expense:	Amount

2018	$	6,619
2019	6,439
2020	6,439
2021	5,624
2022	5,624